Last data update: May 20, 2024. (Total: 46824 publications since 2009)
Records 1-3 (of 3 Records) |
Query Trace: Sumaya CV [original query] |
---|
General recommendations on immunization --- recommendations of the Advisory Committee on Immunization Practices (ACIP)
Kroger AT , Sumaya CV , Pickering LK , Atkinson WL . MMWR Recomm Rep 2011 60 (2) 1-64 This report is a revision of the General Recommendations on Immunization and updates the 2006 statement by the Advisory Committee on Immunization Practices (ACIP) (CDC. General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices [ACIP]. MMWR 2006;55[No. RR-15]). The report also includes revised content from previous ACIP recommendations on the following topics: adult vaccination (CDC. Update on adult immunization recommendations of the immunization practices Advisory Committee [ACIP]. MMWR 1991;40[No. RR-12]); the assessment and feedback strategy to increase vaccination rates (CDC. Recommendations of the Advisory Committee on Immunization Practices: programmatic strategies to increase vaccination rates-assessment and feedback of provider-based vaccination coverage information. MMWR 1996;45:219-20); linkage of vaccination services and those of the Supplemental Nutrition Program for Women, Infants, and Children (WIC program) (CDC. Recommendations of the Advisory Committee on Immunization Practices: programmatic strategies to increase vaccination coverage by age 2 years-linkage of vaccination and WIC services. MMWR 1996;45:217-8); adolescent immunization (CDC. Immunization of adolescents: recommendations of the Advisory Committee on Immunization Practices, the American Academy of Pediatrics, the American Academy of Family Physicians, and the American Medical Association. MMWR 1996;45[No. RR-13]); and combination vaccines (CDC. Combination vaccines for childhood immunization: recommendations of the Advisory Committee on Immunization Practices [ACIP], the American Academy of Pediatrics [AAP], and the American Academy of Family Physicians [AAFP]. MMWR 1999;48[No. RR-5]). Notable revisions to the 2006 recommendations include 1) revisions to the tables of contraindications and precautions to vaccination, as well as a separate table of conditions that are commonly misperceived as contraindications and precautions; 2) reordering of the report content, with vaccine risk-benefit screening, managing adverse reactions, reporting of adverse events, and the vaccine injury compensation program presented immediately after the discussion of contraindications and precautions; 3) stricter criteria for selecting an appropriate storage unit for vaccines; 4) additional guidance for maintaining the cold chain in the event of unavoidable temperature deviations; and 5) updated revisions for vaccination of patients who have received a hematopoietic cell transplant. The most recent ACIP recommendations for each specific vaccine should be consulted for comprehensive details. This report, ACIP recommendations for each vaccine, and additional information about vaccinations are available from CDC at http://www.cdc.gov/vaccines. |
Protecting and enhancing health: community engagement, collaborations, and incentives for prevention
Simoes EJ , Sumaya CV . J Prim Prev 2010 31 21-9 The US health care system and its reform has become a focal point of public debate, engaging many who traditionally have not participated in the dialogue around population health needs and resources. In this essay, we discuss aspects of a transformed health care system that addresses major health needs of Americans through health promotion, disease prevention, and personal health care (i.e., diagnosis and treatment). We bring attention to the role of communities and patients on the health issues with a focus on public (population) health practice, emphasizing collaboration among government health agencies at all levels and other health-related public and private organizations. | This discussion is necessary, relevant, and timely because it is occurring concurrently with the emerging national, state, and local discourse on health reform. Significant funding targeting health system changes are already unfolding with the American Recovery and Reinvestment Act (ARRA) of 2009. (Steinbrook 2009; Agency for Healthcare Research and Quality 2009; US Department of Health & Human Services 2009). |
Recommended adult immunization schedule: United States, 2010
Advisory Committee on Immunization Practices , Baker CJ , Pickering LK , Chilton L , Cieslak P , Ehresmann KR , Englund J , Friedman C , Judson FN , Keitel WA , Lett SM , Plain J , Marcy MS , Meissner CH , Neuzil K , Sawyer MH , Sumaya CV , Temte J . Ann Intern Med 2010 152 (1) 36-9 The Advisory Committee on Immunization Practices (ACIP) annually reviews the Recommended Adult Immunization Schedule (Figure) to ensure that the schedule reflects current recommendations for the licensed vaccines. In October 2009, ACIP approved the Adult Immunization Schedule for 2010, which includes several changes. A bivalent human papillomavirus vaccine (HPV2) was licensed for use in females in October 2009. The ACIP recommends vaccination of females with either HPV2 or the quadrivalent human papillomavirus vaccine (HPV4). HPV4 was licensed for use in males, and the ACIP used a permissive recommendation for use of this vaccine in males. Introductory sentences were added to the footnotes for measles, mumps, rubella, influenza, pneumococcal, hepatitis A, hepatitis B, and meningococcal vaccines. Clarifications were made to the footnotes for measles, mumps, rubella, influenza, hepatitis A, meningococcal, and Haemophilus influenzae type B (Hib) vaccines, and schedule information was added to the hepatitis B vaccine footnote. |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 20, 2024
- Content source:
- Powered by CDC PHGKB Infrastructure